Palo Alto – August 21, 2023 – Cooley advised Andreessen Horowitz (a16z) Bio + Health Tech Investments, an a16z fund with a focus on biotechnology and healthcare technology, in connection with Genesis Therapeutics' oversubscribed $200 million Series B financing. Lawyers Josh Seidenfeld and Thomas Heiser led the Cooley team advising a16z Bio + Health.
Genesis will use proceeds from the round to advance its existing, wholly owned pipeline of artificial intelligence-enabled programs into clinical development, invest in continued development of novel and state-of-the-art generative and predictive AI methods, and expand its pipeline.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.